ACP Advises Point-of-Care Ultrasound to Aid Diagnosis of Dyspnea
MONDAY, May 3, 2021 -- For patients with acute dyspnea with diagnostic uncertainty, point-of-care ultrasound (POCUS) can be a helpful addition to the standard diagnostic pathway, according to a new clinical guideline issued by the American College of Physicians and published online April 27 in the Annals of Internal Medicine.
Gerald Gartlehner, M.D., M.P.H., from Danube University Krems in Austria, and colleagues conducted a systematic review to examine the benefits, harms, and diagnostic test accuracy of POCUS in patients with acute dyspnea. Data were included from five randomized controlled trials and 44 prospective cohort-type studies. The researchers found that for patients with dyspnea, the addition of POCUS to a standard diagnostic pathway yielded statistically significantly more correct diagnoses than the standard diagnostic pathway alone. In most, but not all studies, POCUS consistently improved the sensitivities of standard diagnostic pathways to detect congestive heart failure, pneumonia, pulmonary embolism, pleural effusion, or pneumothorax.
Based on these findings, Amir Qaseem, M.D., Ph.D., from the American College of Physicians in Philadelphia, and colleagues recommend the use of POCUS in addition to the standard diagnostic pathway among patients with acute dyspnea in the emergency department or inpatient setting for whom there is diagnostic uncertainty.
"This recommendation applies to clinical scenarios where there is diagnostic uncertainty," Qaseem and colleagues write. "Clinicians should understand and consider that the test accuracy of POCUS varies according to the likelihood of underlying diseases."
© 2021 HealthDay. All rights reserved.
Posted: May 2021
Read this next
THURSDAY, May 13, 2021 -- An artificial intelligence (AI) system can predict deterioration of COVID-19 patients in the emergency department, according to a study published online...
THURSDAY, May 13, 2021 -- Integration of data from multiple, noninvasive biomarkers can improve risk assessment of patients with a clinical suspicion of prostate cancer prior to...
THURSDAY, May 13, 2021 -- Neighborhood disadvantage is independently associated with increased mortality after myocardial infarction (MI), according to a study presented at the...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.